Skip to content

Effect of adding dexmedetomidine to local anaesthetic wound infiltration for post surgery pain relief

The effect of dexmedetomidine as an adjuvant to ropivacaine for wound infiltration in providing postoperative analgesia for open abdominal surgeries.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017736
Enrollment
90
Registered
2019-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K918- Other intraoperative and postprocedural complications and disorders of digestive system

Interventions

Intervention1: Dr.Sumadhu: MD, SVIMS, Tirupati Intervention2: Dr.Aloka Samantaray: professor and HOD Dept Anesthesiology SVIMS, Tirupati Intervention3: Dr.Sumadhu: MD, SVIMS Intervention4: Tramadol an

Sponsors

Svims
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients scheduled to undergo elective open abdominal surgeries at SVIMS. 2.Patients belonging to ASA physical status 1,2 and 3. 3.Age group between 18 and 65 years.

Exclusion criteria

Exclusion criteria: 1.Patient refusal to participate in the study. 2.Severe hepatic/cardiac/renal disorders. 3.Pre existing neurological deficits/psychiatric illness/metabolic disorders. 4.Allergic reaction to the study drugs. 5.History of chronic analgesic usage(on oral analgesics for more than one month). 6.Pregnant and lactating mothers. 7.Patients who cannot understand and interpret NRS.

Design outcomes

Primary

MeasureTime frame
The magnitude of pain using NRS at fixed time intervalTimepoint: At 0hr,2hr,4hr,6hr,12hr&24hr.

Secondary

MeasureTime frame
Analgesic requirement in first 24 hours after surgery. The time to the first request of rescue analgesia. Timepoint: 6 months

Countries

India

Contacts

Public ContactAloka Samantaray

Sri venkateswara institute of medical sciences

aloksvims@gmail.com9493547653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026